Filing Details
PULSE BIOSCIENCES, INC. (NASDAQ:PLSE) filed a Form 8-K with the Securities and Exchange Commission on July 29, 2026, disclosing a material event.
8k filedNASDAQ:PLSE
PULSE BIOSCIENCES, INC. (PLSE) Reports Material Event to SEC
Filing Details PULSE BIOSCIENCES, INC. (NASDAQ:PLSE) filed a Form 8-K with the Securities and Exchange Commission on July 29, 2026, disclosing a material event. Market Context…
Market Context
PULSE BIOSCIENCES, INC.'s stock currently trades at $34.25 with a market capitalization of $933.2M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for PULSE BIOSCIENCES, INC.'s stock.
All SEC filings for PULSE BIOSCIENCES, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View PLSE Stock Page
Frequently Asked Questions
Where can I read PLSE's SEC filings?
Browse all filings on our PLSE SEC filings page.
What types of SEC filings does PULSE BIOSCIENCES, INC. file?
Public companies like PULSE BIOSCIENCES, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.